ADAC expects slightly lower Q1 revenues

Article

ADAC Laboratories reported last week that it was expecting topost revenues of about $44 million for its first fiscal quarter(end-January), down slightly from the $46.5 million registeredin the same period last year. Earnings per share will be

ADAC Laboratories reported last week that it was expecting topost revenues of about $44 million for its first fiscal quarter(end-January), down slightly from the $46.5 million registeredin the same period last year. Earnings per share will be about15¢ a share, compared to 23¢ per share in the firstquarter of 1994.

The figures meet ADAC's expectations for the quarter, accordingto president and CEO David Lowe. ADAC, of Milpitas, CA, also saidit is progressing in its negotiations to acquire parts of CommunityHealth Computing, the radiology information systems vendor thatfiled for Chapter 11 last month (SCAN 12/14/94).

Newsletter

Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.

Recent Videos
SNMMI: Emerging PET Insights on Neuroinflammation with Progressive Apraxia of Speech (PAOS) and Parkinson-Plus Syndrome
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
Related Content
© 2025 MJH Life Sciences

All rights reserved.